WhatsApp
backNews Article

Caplin Point Laboratories Reports Rs 130.51 Crore Net Profit for Q2 FY2026-27 on Rs 241.88 Crore Revenue

Company posts Rs 250.89 crore net profit for H1 FY2026-27 with earnings per share of Rs 33.01, as standalone revenue reaches Rs 444.83 crore

Caplin Point Laboratories Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, reporting a net profit of Rs 130.51 crore for Q2 and Rs 250.89 crore for H1 FY2026-27, driven by Rs 241.88 crore revenue in Q2 and Rs 444.83 crore in H1. The company declared earnings per share of Rs 17.17 for Q2 and Rs 33.01 for H1, reflecting improved profitability over the period.

7 days ago|CAPLIPOINT-2.31%
Caplin Point Laboratories Limited524742CAPLIPOINTInvestor Presentation

Caplin Point Laboratories Limited

Investor Presentation

Caplin Point Laboratories Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, reporting a net profit of Rs 130.51 crore for the quarter backed by Rs 241.88 crore revenue from operations.

The company recorded total income of Rs 292.92 crore in the quarter ending September 30, 2026, including other income of Rs 51.04 crore.

Total expenses during the quarter were Rs 125.87 crore, including cost of materials consumed at Rs 48.06 crore and employee benefits expense of Rs 13.55 crore.

Profit before tax for the quarter stood at Rs 167.05 crore, with current tax expenses of Rs 36.79 crore resulting in net profit of Rs 130.51 crore.

Earnings per share (basic) for the quarter was Rs 17.17, and for the half year Rs 33.01, based on a share capital of Rs 15.20 crore (face value Rs 2 per share).

The standalone half year results showed total income of Rs 558.66 crore with net profit of Rs 250.89 crore, compared to Rs 188.48 crore net profit in the corresponding previous period.

Highlights

  • Quarterly revenue from operations: Rs 241.88 crore
  • Quarterly net profit: Rs 130.51 crore
  • Half year revenue from operations: Rs 444.83 crore
  • Half year net profit: Rs 250.89 crore
  • Basic earnings per share (Q2): Rs 17.17
  • Basic earnings per share (H1): Rs 33.01

Key Data Snapshot

Quarter ended30.09.2026
Revenue from operationsRs 241.88 crore
Other incomeRs 51.04 crore
Total incomeRs 292.92 crore
Total expensesRs 125.87 crore
Profit before taxRs 167.05 crore
Current tax expenseRs 36.79 crore
Net profitRs 130.51 crore
Basic earnings per shareRs 17.17
Paid up equity share capitalRs 15.20 crore (face value Rs 2 per share)
Half year net profitRs 250.89 crore
Half year revenue from operationsRs 444.83 crore

What happened

  • Caplin Point Laboratories approved unaudited standalone financial results for quarter and half year ended September 30, 2026.
  • The company reported a standalone net profit of Rs 130.51 crore for Q2 and Rs 250.89 crore for H1 FY2026-27.
  • Revenue from operations stood at Rs 241.88 crore for the quarter and Rs 444.83 crore for the half year.

Financial performance

  • Total income for Q2 was Rs 292.92 crore including Rs 51.04 crore other income.
  • Total expenses for Q2 were Rs 125.87 crore with material costs and employee benefits as major components.
  • Profit before tax was Rs 167.05 crore in the quarter, with tax expenses of Rs 36.54 crore.
  • Earnings per share for the quarter were Rs 17.17 basic and Rs 17.12 diluted.

Background and context

  • Results are prepared as per Indian Accounting Standards and reviewed by the Audit Committee and statutory auditors.
  • The company operates solely in pharmaceutical formulations segment.
  • No separate segment reporting is provided as company has a single business segment.

More News on Investor Presentation

View all

Latest corporate announcements and market updates in Investor Presentation.

View all news
Caplin Point Laboratories Reports Rs 130.51 Crore Net | Stockk News